Non-specialised wholesale trade
NEPTUNE PHARMA AS
Revenue 2024
NOK 1.1m
Operating profit
NOK −286,000
Equity
NOK −1.5m
Incorporated
2018
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 1.1m | |
| Total operating costs | 1.4m | |
| Operating profit (EBIT) | −286k | |
| Net financial items | −3k | |
| Profit for the year | −289k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 1.5m | |
| of which current assets | 1.1m | |
| Equity | −1.5m | |
| Total liabilities | 3.1m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.